Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ADMA
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 42,000 | $12.00 | $504.0K Sale | Form 4 ↗ |
| Nov 5, 2026 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 105,000 | $12.00 | $1.3M Sale | Form 4 ↗ |
| May 27, 2026 | Jerrold B. Grossman Director | ADMA ADMA Biologics Inc | Buy | 6,400 | $7.91 | $50.6K Buy | Form 4 ↗ |
| May 12, 2026 | Jerrold B. Grossman Director | ADMA ADMA Biologics Inc | Buy | 12,500 | $8.01 | $100.1K Buy | Form 4 ↗ |
| May 11, 2026 | Jerrold B. Grossman Director | ADMA ADMA Biologics Inc | Buy | 12,500 | $8.01 | $100.1K Buy | Form 4 ↗ |
| Mar 16, 2026 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $15.16 | $91.0K Sale | Form 4 ↗ |
| Mar 16, 2026 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $15.16 | $227.4K Sale | Form 4 ↗ |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | ADMA ADMA Biologics Inc | Sale | 10,096 | $15.63 | $157.8K Sale | Form 4 ↗ |
| Mar 6, 2026 | Steve Elms Director | ADMA ADMA Biologics Inc | Buy | 7,000 | $15.39 | $107.7K Buy | Form 4 ↗ |
| Mar 5, 2026 | Steve Elms Director | ADMA ADMA Biologics Inc | Buy | 7,000 | $15.67 | $109.7K Buy | Form 4 ↗ |
| Feb 17, 2026 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $16.08 | $96.5K Sale | Form 4 ↗ |
| Feb 17, 2026 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $16.08 | $241.2K Sale | Form 4 ↗ |
| Dec 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $19.79 | $118.7K Sale | Form 4 ↗ |
| Dec 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $19.79 | $296.9K Sale | Form 4 ↗ |
| Nov 19, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $16.00 | $96.0K Sale | Form 4 ↗ |
| Nov 19, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $16.00 | $240.0K Sale | Form 4 ↗ |
| Oct 24, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $16.00 | $96.0K Sale | Form 4 ↗ |
| Oct 24, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $16.00 | $240.0K Sale | Form 4 ↗ |
| Sep 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $16.13 | $96.8K Sale | Form 4 ↗ |
| Sep 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $16.13 | $241.9K Sale | Form 4 ↗ |
| Aug 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $16.88 | $101.3K Sale | Form 4 ↗ |
| Aug 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $16.88 | $253.2K Sale | Form 4 ↗ |
| Jul 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $18.66 | $112.0K Sale | Form 4 ↗ |
| Jul 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $18.66 | $279.9K Sale | Form 4 ↗ |
| Jun 16, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $20.81 | $124.9K Sale | Form 4 ↗ |
| Jun 16, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $20.81 | $312.1K Sale | Form 4 ↗ |
| Jun 16, 2025 | Steve Elms Director | ADMA ADMA Biologics Inc | Sale | 194,749 | $20.24 | $3.9M Sale | Form 4 ↗ |
| Jun 13, 2025 | Steve Elms Director | ADMA ADMA Biologics Inc | Sale | 137,931 | $20.82 | $2.9M Sale | Form 4 ↗ |
| Jun 12, 2025 | Steve Elms Director | ADMA ADMA Biologics Inc | Sale | 92,941 | $21.69 | $2.0M Sale | Form 4 ↗ |
| Jun 9, 2025 | Lawrence P. Guiheen Director | ADMA ADMA Biologics Inc | Sale | 20,000 | $20.96 | $419.2K Sale | Form 4 ↗ |
| Jun 9, 2025 | Jerrold B. Grossman Director | ADMA ADMA Biologics Inc | Sale | 10,000 | $21.31 | $213.1K Sale | Form 4 ↗ |
| May 22, 2025 | Lawrence P. Guiheen Director | ADMA ADMA Biologics Inc | Sale | 1,221 | $20.12 | $24.6K Sale | Form 4 ↗ |
| May 21, 2025 | Lawrence P. Guiheen Director | ADMA ADMA Biologics Inc | Sale | 7,779 | $20.32 | $158.1K Sale | Form 4 ↗ |
| May 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $19.45 | $116.7K Sale | Form 4 ↗ |
| May 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $19.45 | $291.8K Sale | Form 4 ↗ |
| Apr 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $21.46 | $128.8K Sale | Form 4 ↗ |
| Apr 15, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $21.46 | $321.9K Sale | Form 4 ↗ |
| Mar 19, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 6,000 | $18.92 | $113.5K Sale | Form 4 ↗ |
| Mar 19, 2025 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 15,000 | $18.92 | $283.8K Sale | Form 4 ↗ |
| Nov 22, 2024 | Brad L. Tade CFO and Treasurer | ADMA ADMA Biologics Inc | Sale | 15,000 | $21.15 | $317.3K Sale | Form 4 ↗ |
| Nov 22, 2024 | Adam S. Grossman President and CEO, Director | ADMA ADMA Biologics Inc | Sale | 48,967 | $21.10 | $1.0M Sale | Form 4 ↗ |
41 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:13 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances